Cargando…
COVID-19 and immunomodulation in IBD
The current coronavirus pandemic is an ongoing global health crisis due to COVID-19, caused by severe acute respiratory syndrome coronavirus 2. Although COVID-19 leads to little or mild flu-like symptoms in the majority of affected patients, the disease may cause severe, frequently lethal complicati...
Autor principal: | Neurath, Markus F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211083/ https://www.ncbi.nlm.nih.gov/pubmed/32303609 http://dx.doi.org/10.1136/gutjnl-2020-321269 |
Ejemplares similares
-
MicroRNAs: new players in IBD
por: Kalla, R, et al.
Publicado: (2015) -
Organoids in gastrointestinal diseases: from experimental models to clinical translation
por: Günther, Claudia, et al.
Publicado: (2022) -
Big data in IBD: big progress for clinical practice
por: Seyed Tabib, Nasim Sadat, et al.
Publicado: (2020) -
Liver sampling: a vital window into HBV pathogenesis on the path to functional cure
por: Gill, Upkar S, et al.
Publicado: (2018) -
Calprotectin: from biomarker to biological function
por: Jukic, Almina, et al.
Publicado: (2021)